In a blockbuster move that sent shockwaves through the NFL, the Green Bay Packers acquired star pass rusher Micah Parsons from the Dallas Cowboys in exchange for two first-round picks and defensive tackle Kenny Clark. The trade, finalized just before the 2025 season, was expected to bolster Green Bay’s defense and elevate their standing in the fiercely competitive NFC North. However, the excitement surrounding Parsons’ arrival has been tempered by concerns over a lingering back injury that could delay his highly anticipated debut.
According to ESPN, Parsons is battling an L4/L5 facet joint sprain in his back, an injury that dates back to his time with the Cowboys. The 26-year-old linebacker, known for his explosive playmaking and relentless pass-rushing ability, was listed as a limited participant in the Packers’ injury reports on both Wednesday and Thursday. Reports indicate that Parsons may require an epidural injection to manage pain and inflammation, raising questions about his availability for Week 1.
“I’m still ramping up,” Parsons told ESPN. “It’s a process of getting ready for football. Being out for six months, obviously, going through the tightness, the soreness, but I just got plenty of faith that this great training staff and the coaches are slowly getting me the plays and getting me things that I need if we decide to give me the green light out there. It’s completely up to the coaches, though.”
Parsons’ injury concerns are not new. During his final season with the Cowboys, he missed four games due to a high ankle sprain and also sat out portions of training camp as he recovered and negotiated a long-term contract. The back issue, however, appears to be a more persistent challenge. Parsons noted that he recently completed a steroid pack prescribed by the Cowboys’ medical staff, expressing hope that it, combined with ongoing treatment, will help him return to full health.
“We’re just going to see about that,” Parsons said regarding the possibility of needing an epidural injection. “Right now, we just took the steroid pack that I got from the Cowboys last week, and we started that last week while I was getting treatment there. … We finished the pack and hopefully that works plus treatment to get me back to 100 [percent].”
The uncertainty surrounding Parsons’ status has left Packers fans on edge. A matchup against the Detroit Lions, a bitter NFC North rival, is a critical opportunity for Green Bay to set the tone for the season. Parsons, who signed a lucrative four-year, $188 million contract with $120 million guaranteed upon his arrival in Green Bay, was expected to be a cornerstone of the Packers’ defense. His absence could significantly impact the team’s ability to contain Detroit’s high-powered offense.
Parsons’ durability has been a hallmark of his career. Over his four-year tenure with the Cowboys, he missed only those four games last season, showcasing his resilience and ability to perform at an elite level. His transition to Green Bay was seen as a fresh start, with the new contract resolving the lingering tensions from his Dallas negotiations. Yet, the back injury now threatens to derail the excitement surrounding his move.
The Packers’ coaching and medical staff face a pivotal decision. Rushing Parsons back too soon could exacerbate the injury, potentially sidelining him for an extended period. Conversely, a cautious approach might mean missing a key player in a high-stakes divisional showdown. Head coach Matt LaFleur and the training staff will likely monitor Parsons’ progress closely in the days leading up to the game, with a final call expected closer to kickoff.
For now, Packers fans can only hope that their new star can overcome this setback and take the field against the Lions. A healthy Micah Parsons could be the difference-maker in securing a statement win to open the season. Until then, the NFC North waits anxiously to see if Green Bay’s bold trade will pay immediate dividends or if Parsons’ debut will be delayed by this devastating injury.